Aflac’s Tomlinson Retires Due to Health a Year After Promotion

Updated on

Aflac Inc. said Michael Tomlinson is stepping down as director of U.S. sales to focus on his health, less than a year after taking the role.

Andrew Glaub, 55, was promoted to replace him, according to a statement Thursday from Columbus, Georgia-based Aflac, the largest seller of supplemental health insurance.

Aflac overhauled its U.S. operation last year to counter a sales slump. John Shelby Amos, a cousin of Chief Executive Officer Dan Amos, stepped down from the board of directors to help the effort, and Tomlinson, 57, was promoted from his job as director for the U.S. Central Territory.

“Without Mike’s leadership and expertise, the very important work last year related to the sales model changes would not have been accomplished,” the CEO said in the statement. “As Aflac pursues its strategy designed to boost sales and foster growth in the U.S. market, Andy Glaub is the ideal person to lead the charge.”

The insurer slipped 4 percent this year in New York trading after falling 8.6 percent in 2014. Aflac said that Tomlinson will still serve the company as an adviser.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE